Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab.

Adam, Zdenek; Cermák, Ales; Petrásová, Hana; Rehák, Zdenek; Koukalová, Renata; Fojtík, Zdenek; Pour, Ludek; Boichuk, Ivanna; Krejcí, Marta; Král, Zdenek; Benda, Petr

Adam, Zdenek; Cermák, Ales; Petrásová, Hana; Rehák, Zdenek; Koukalová, Renata; Fojtík, Zdenek; Pour, Ludek; Boichuk, Ivanna; Krejcí, Marta; Král, Zdenek; Benda, Petr.

Vnitr Lek ; 69(E-3): 4-15, 2023.

Article in En | MEDLINE | ID: mdl-37468330

Subject(s)

Immunoglobulin G4-Related Disease; Retroperitoneal Fibrosis; Male; Humans; Middle Aged; Glucocorticoids/therapeutic use; Rituximab/therapeutic use; Retroperitoneal Fibrosis/complications; Retroperitoneal Fibrosis/drug therapy; Retroperitoneal Fibrosis/diagnosis; Positron Emission Tomography Computed Tomography; Immunoglobulin G4-Related Disease/complications; Immunoglobulin G4-Related Disease/drug therapy; Fluorodeoxyglucose F18/therapeutic use; Cyclophosphamide/therapeutic use; Dexamethasone/therapeutic use; Immunoglobulin G/therapeutic use

Key words

Cyclophosphamide; IgG4 related disease; cyclophosphamide; retroperitoneal fibrosis; rituximab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Fibrosis / Immunoglobulin G4-Related Disease Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Vnitr Lek Year: 2023 Document type: Article Country of publication: Czech Republic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google